Ref |
Description |
Final Response |
148/19/FOI |
Questions relating to patients recording consultations |
148 19 FOI Final Response.docx |
149/19/FOI |
Tawel Fan nursing staff |
|
150/19/FOI |
Radiology Staffing |
|
151/19/FOI |
Staff tattoos |
|
152/19/FOI |
Kawasaki Disease admissions |
|
153/19/FOI |
Vacant nursing posts |
|
154/19/FOI |
Date of employment commencing and date of contract ending |
|
157/19/FOI |
NHS Prescriptions |
|
158/19/FOI |
Questions relating to Occupational Therapy Service |
Withdrawn |
159/19/FOI |
Palliative care nurses |
159 19 FOI Final Response.docx |
160/19/FOI |
Questions relating to staff bank solution |
|
161/19/FOI |
Ablett Mental Health Unit |
161 19 FOI Final Response AMENDED (1).docx |
162/19/FOI |
Salary and expenses of Chief Executive and Chairman 2018/19 |
162 19 FOI Final Response.docx |
163/19/FOI |
Charity funding |
163 19 FOI Final Response.docx |
164/19/FOI |
Conwy and Denbighshire Mental Health Advocacy Service funding |
|
165/19/FOI |
Caniad funding |
|
166/19/FOI |
Pessary Care |
|
167/19/FOI |
Salary, expenses and bonuses of Chief Executive and Chairman 2017 |
|
168/19/FOI |
Director of Mental Health and Learning Disabilities salary, expenses, bonus, sick pay |
|
169/19/FOI |
Together for Mental Health Summit costs |
|
170/19/FOI |
Questions regarding domestic abuse policies |
|
171/19/FOI |
Questions regarding intravenous oxytocin infusion for induction of labour, postpartum haemorrhage, and blood transfusions |
|
172/19/FOI |
Following on from 074/19/FOI |
|
173/19/FOI |
Hospital appointment no-shows |
|
174/19/FOI |
Questions regarding Heart Valve Disease |
|
177/19/FOI |
Gambling addiction |
177 19 FOI Final Response.doc |
178/19/FOI |
Cutaneous Squamous Cell Carcinoma |
|
179/19/FOI |
Incidents involving oxygen equipment, fire and fatalities |
179 19 FOI Final Response.docx |
180/19/FOI |
ICT Strategy, organisational chart, annual plan and capital programme |
180 19 FOI Final Response.doc |
182/19/FOI |
Failed discharges YGC |
182 19 FOI Final Response.doc |
183/19/FOI |
Genetic haemochromatosis |
|
184/19/FOI |
Pharmaceutical product rebate agreements |
|
185/19/FOI |
Infected Blood Inquiry |
|
186/19/FOI |
Procurement plans in place regarding NICE guidance DG34 -tumour profiling |
|
187/19/FOI |
Psychological support following pregnancy/baby loss |
|
188/19/FOI |
Questions regarding bank/agency spend and contracts |
|
189/19/FOI |
Questions regarding Specialist Skin Cancer Multidisciplinary Team |
|
190/19/FOI |
Complaints received |
190 19 FOI Final Response.doc |
191/19/FOI |
Staffing levels |
191 19 FOI Final Response.doc |
192/19/FOI |
Aberconwy Mind funding |
192 19 FOI Final Response.doc
|
193/19/FOI |
Hafal Funding |
|
194/19/FOI |
C.A.L.L Mental Health Hotline funding |
|
195/19/FOI |
Parabl Funding |
|
196/19/FOI |
CAIS Funding |
|
197/19/FOI |
Overseas patients invoiced |
|
199/19/FOI |
Questions relating to PACE trial for CFS/ME |
199 19 FOI Final Response.doc |
200/19/FOI |
Questions relating to CFS/ME |
200 19 FOI Final Response.docx |
201/19/FOI |
Questions relating to Homozygous Familial Hypercholesterolaemia (HoFH) |
|
202/19/FOI |
Questions relating to audio visual and video conferencing equipment and services |
|
203/19/FOI |
Incident rates, performance rates and mortality rates for two Consultants |
203 19 FOI Final Response.doc |
204/19/FOI |
Questions relating to apprenticeships |
204 19 FOI Final Response.docx |
205/19/FOI |
Cancelled operations 15/16 - 18/19 by speciality |
|
206/19/FOI |
E-mails and text messages between Gary Doherty and Chairman of the Independent Oversight Panel |
206 19 FOI Final Response AMENDED.docx |
207/19/FOI |
Spend on rented oxygen bottles |
|
208/19/FOI |
Type 1 diabetes and glucose monitoring |
|
223/19/FOI |
Questions regarding Head and Neck MDT |
|
224/19/FOI |
Following on from 149/19/FOI regarding Tawel Fan nursing staff |